BioSpace News Archive

Transparency Market Research has published a new report titled, ‘Mobile Imaging Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

According to the report, the global pelvic floor electrical stimulation devices market was valued at US$ 300 Mn in 2019 and is projected to expand at a CAGR of 9.5% from 2020 to 2030.

According to the report, the global teleradiology services market was valued over US$ 6.4 Bn in 2020.

Tiziana Life Sciences plc, a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, announced an interview with CEO and CSO Dr. Kunwar Shailubhai will air on The RedChip Money Report on the Bloomberg Network in the U.S. on Saturday, May 8 at 7 p.m. local time.

Gyroscope Therapeutics Holdings plc, a clinical-stage gene therapy company focused on treating diseases of the eye, announced it has postponed plans for its initial public offering.

Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call and audio webcast on Friday, May 14, 2021 at 8:30 a.m. ET to report financial results for the first quarter ended March 31, 2021 and to provide a business overview.

Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today reported financial and operating results for the three months ended March 31, 2021. All financial amounts in this news release are in United States dollars, unless otherwise stated.

Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, today announced the appointment of Dr. Kathy Reape as chief development officer.

Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST) announces it has entered into a definitive agreement to acquire Grace Therapeutics, Inc. (“Grace”), a privately held emerging biopharmaceutical company focused on developing innovative drug delivery technologies for the treatment of rare and orphan diseases (the “Proposed Transaction”).

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is joining Mental Health America (MHA) and other advocacy organizations in observing May is Mental Health Month, by raising awareness of and supporting people living with depression, anxiety, and other mental health conditions. MHA is the nation’s leading community-based nonprofit organization dedicated to addressing the needs of those living with mental illness and promoting overall mental health.